| Literature DB >> 35530728 |
Takaaki Sato1, Mutsumi Matsukawa2, Toshio Iijima3, Yoichi Mizutani4.
Abstract
Odors trigger various emotional responses such as fear of predator odors, aversion to disease or cancer odors, attraction to male/female odors, and appetitive behavior to delicious food odors. Odor information processing for fine odor discrimination, however, has remained difficult to address. The olfaction and color vision share common features that G protein-coupled receptors are the remote sensors. As different orange colors can be discriminated by distinct intensity ratios of elemental colors, such as yellow and red, odors are likely perceived as multiple elemental odors hierarchically that the intensities of elemental odors are in order of dominance. For example, in a mixture of rose and fox-unique predator odors, robust rose odor alleviates the fear of mice to predator odors. Moreover, although occult blood odor is stronger than bladder cancer-characteristic odor in urine samples, sniffer mice can discriminate bladder cancer odor in occult blood-positive urine samples. In forced-choice odor discrimination tasks for pairs of enantiomers or pairs of body odors vs. cancer-induced body odor disorders, sniffer mice discriminated against learned olfactory cues in a wide range of concentrations, where correct choice rates decreased in the Fechner's law, as perceptual ambiguity increased. In this mini-review, we summarize the current knowledge of how the olfactory system encodes and hierarchically decodes multiple elemental odors to control odor-driven behaviors.Entities:
Keywords: biomarkers; body odor disorder; cancer-characteristic odors; fear and relaxation; odor discrimination; odor information coding; sniffer mouse behaviors
Year: 2022 PMID: 35530728 PMCID: PMC9074825 DOI: 10.3389/fnbeh.2022.849864
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Figure 1Hierarchical elemental odor coding in olfaction. (A) Schematic diagram of similar but different odors of carvone enantiomers in a hierarchical elemental odor coding. Predicted relative intensities of elemental odors differ between the enantiomers. (B) Olfactory pathway from the olfactory epithelium to the olfactory cortex (Modified from Sato et al., 2008). Pyramidal cells in the anterior piriform cortex, where elemental odors are likely represented by addition and subtraction between signals from multiple receptors via the feedforward inhibitory signals, are the third neurons from sensory neurons (Sato et al., 2007, 2014). Predator odors activate the amygdala, the bed nucleus of the stria terminalis (BST), and the anterior pituitary resulting in an increase of adrenocorticotrophic hormone (ACTH) to reduce fear stress (see Matsukawa's review in this collection). (C) Schematic diagram of receptor signal integrations for principal elemental odors among cognate receptors by inhibitory signals (Sato et al., 2007, 2014, 2016c). These are the cases of carvone enantiomers at the initial phase of odor response and around the peak of receptor responses (See text for the details).
Figure 2Odor discrimination thresholds of wild-type (WT) and ΔD mice for bladder and prostate cancers and healthy volunteer dietary variation (Sato et al., 2017, 2021). (A) Odor discrimination of WT (black closed circles) and ΔD mice (red open squares) between equi-occult blood pre**- vs. post*-transurethral resection (post*-TUR) urine mixture (Um) of five patients with bladder cancer (Sato et al., 2017). ΔD mice showed a marked elevation of discrimination threshold for bladder cancer odor (pre-TUR odor) vs. post-TUR odor. Post-assays, 10−6 pre**- vs. post*-TUR Um and identical Um pair: 10−6 pre**- vs. pre**-TUR Um. The percent correct (%Correct) for a training odor pair−10−5 R-(–) carvone [(–)car] (w/w) vs. solvent [di(propylene)glycol] just before the urine discrimination assay is shown on the left side. Linear regression models are shown around the thresholds (gray or red dashed lines). Two alternative forced choice assays with target vs. non-target odors were performed in a Y-maze. Tasks performed at thresholds are marked by the star. Chain lines indicate the %Correct significantly above chance performance (P = 0.05). Black arrowheads indicate chance levels (50%). (B) Urine odor discrimination between a pair of healthy (H) urine mixtures—six volunteers' 1st-3rd sample (H1–3) vs. 4th-6th sample (H4–6) Um. ΔD mice could not discriminate the healthy volunteer urine pair. Post assays: 10−7 and 10−5 (–)car vs. solvent for WT and ΔD mice, respectively. (C) Odor discrimination of sniffer mice between equal-occult blood pre‡- vs. post†-radical prostatectomy (post†-RP) Um of five patients with prostate cancer (Sato et al., 2021). Post-assays, 10−4 P:Um pair: 10−4 pre‡- vs. post†-RP P:Um, 10−6 N:Um pair: pre**- vs. post*-TUR of bladder cancer N:Um and identical P:Um pair: 10−4 pre‡- vs. pre‡-RP P:Um. The percent correct (%Correct) for a training odor pair−10−6 N:Um pair just before the prostate cancer urine discrimination assay is shown on the left side. On the right side, the identical %Correct between pairs of pre‡- vs. post†-RP Um and post‡-RP + biomarker (BM) Um (prostate cancer odor mimic) vs. post†-RP Um, and by chance choice for identical pre‡-RP Um pair are shown. Extra-dilution rates for equal-occult blood Ums are 1/13** v/v, 1/6* v/v, 1/50‡ v/v, and 1/2† v/v. The lower panel shows concentrations (ppb) (-fold of healthy control) of respective peak compounds in the respective original samples, and concentration″ (ppq) in the (106 × extra rate)-fold diluted urine samples. (E) After neoadjuvant endocrine therapy. “≈” means <2 ratios of paired sample concentrations. Biomarker compounds for peaks are #81, phenol; #101, dimethyl succinate; #104, acetophenone; #109, 2-phyenyl-2-propanol; #119, 3,5,5-trimethyl-2-cyclohexenone; #123, dimethyl glutarate; #152, piperitone; #155, 2-hydroxy-2-methylpropiophenone; #165, 2,6-di(propan-2-yl)phenol. (D) Odor discrimination thresholds of sniffer mice for urinary olfactory cues (Sato et al., 2017, 2021). Odor discrimination ranges (downward arrows) and thresholds (stars) of WT (black plots) and ΔD mice (red plots) for urinary olfactory cues are shown. Observed threshold differences indicate that urinary olfactory cues increase in the following order: dietary variation < bladder cancer < occult blood < prostate cancer (after neoadjuvant endocrine therapy) < antibiotic drug metabolites < prostate cancer. ΔD mice exhibited reduced odor discrimination sensitivities, compared to WT mice; degrees of sensitivity reductions due to ablation of dorsal olfactory receptors are indicated by the red upward arrows. Range of actual concentrations of urine mixture samples for prostate cancer examination in 106-fold diluted equal-occult blood conditions ranged from 1.0 × 10−6 v/v (black open circle) to 7.1 × 10−9 v/v (gray open circle). (E) Schematic diagram for discrimination between similar but distinct cancer odors (Sato et al., 2021). The sniffer mice would discriminate disease-biomarker odors based on the relative ratio of biomarkers for cancers (cancer-characteristic + cancer-common compounds) vs. urine-characteristic compounds. Overlapping regions contain compounds common to different cancers or cancers and healthy variations, leading to odor similarity, whereas non-overlapping regions contain status-characteristic compounds, leading to an odor-cue mismatch.